337 related articles for article (PubMed ID: 31062373)
1. Influence of Calcineurin Inhibitor and Sex on Mycophenolic Acid Pharmacokinetics and Adverse Effects Post-Renal Transplant.
Meaney CJ; Sudchada P; Consiglio JD; Wilding GE; Cooper LM; Venuto RC; Tornatore KM
J Clin Pharmacol; 2019 Oct; 59(10):1351-1365. PubMed ID: 31062373
[TBL] [Abstract][Full Text] [Related]
2. Association of ABCC2 Haplotypes to Mycophenolic Acid Pharmacokinetics in Stable Kidney Transplant Recipients.
Brazeau D; Meaney CJ; Consiglio JD; Wilding GE; Cooper LM; Venuto RC; Tornatore KM
J Clin Pharmacol; 2021 Dec; 61(12):1592-1605. PubMed ID: 34169529
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.
Atcheson BA; Taylor PJ; Mudge DW; Johnson DW; Hawley CM; Campbell SB; Isbel NM; Pillans PI; Tett SE
Br J Clin Pharmacol; 2005 Mar; 59(3):271-80. PubMed ID: 15752372
[TBL] [Abstract][Full Text] [Related]
4. Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients.
Tornatore KM; Meaney CJ; Wilding GE; Chang SS; Gundroo A; Cooper LM; Gray V; Shin K; Fetterly GJ; Prey J; Clark K; Venuto RC
Clin Pharmacokinet; 2015 Apr; 54(4):423-34. PubMed ID: 25511793
[TBL] [Abstract][Full Text] [Related]
5. Influence of Calcineurin Inhibitors and Genetic Polymorphism of Transporters on Enterohepatic Circulation and Exposure of Mycophenolic Acid in Chinese Adult Renal Allograft Recipients.
Sun SS; Shao K; Lu JQ; An HM; Shi HQ; Zhou PJ; Chen B
J Clin Pharmacol; 2023 Apr; 63(4):410-420. PubMed ID: 36394393
[TBL] [Abstract][Full Text] [Related]
6. Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities.
Tornatore KM; Attwood K; Venuto RC; Murray B
Clin Transl Sci; 2023 May; 16(5):861-871. PubMed ID: 36840340
[TBL] [Abstract][Full Text] [Related]
7. How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not.
van Gelder T
Kidney Int; 2021 Dec; 100(6):1185-1189. PubMed ID: 34284043
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
[TBL] [Abstract][Full Text] [Related]
9. Impact of changing from cyclosporine to tacrolimus on pharmacokinetics of mycophenolic acid in renal transplant recipients with diabetes.
Park JM; Lake KD; Cibrik DM
Ther Drug Monit; 2008 Oct; 30(5):591-6. PubMed ID: 18708992
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.
van Gelder T; Klupp J; Barten MJ; Christians U; Morris RE
Ther Drug Monit; 2001 Apr; 23(2):119-28. PubMed ID: 11294511
[TBL] [Abstract][Full Text] [Related]
11. Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
J Clin Pharmacol; 2003 Aug; 43(8):866-80. PubMed ID: 12953344
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
[TBL] [Abstract][Full Text] [Related]
13. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
[TBL] [Abstract][Full Text] [Related]
14. Steady-state pharmacokinetics of mycophenolic acid in renal transplant patients: exploratory analysis of the effects of cyclosporine, recipients' and donors' ABCC2 gene variants, and their interactions.
Božina N; Lalić Z; Nađ-Škegro S; Borić-Bilušić A; Božina T; Kaštelan Ž; Trkulja V
Eur J Clin Pharmacol; 2017 Sep; 73(9):1129-1140. PubMed ID: 28624888
[TBL] [Abstract][Full Text] [Related]
15. Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation.
Naito T; Shinno K; Maeda T; Kagawa Y; Hashimoto H; Otsuka A; Takayama T; Ushiyama T; Suzuki K; Ozono S
Biol Pharm Bull; 2006 Feb; 29(2):275-80. PubMed ID: 16462031
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
[TBL] [Abstract][Full Text] [Related]
17. Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients.
Tornatore KM; Meaney CJ; Attwood K; Brazeau DA; Wilding GE; Consiglio JD; Gundroo A; Chang SS; Gray V; Cooper LM; Venuto RC
Pharmacotherapy; 2022 Feb; 42(2):94-105. PubMed ID: 35103348
[TBL] [Abstract][Full Text] [Related]
18. Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling.
Cremers S; Schoemaker R; Scholten E; den Hartigh J; König-Quartel J; van Kan E; Paul L; de Fijter J
Br J Clin Pharmacol; 2005 Sep; 60(3):249-56. PubMed ID: 16120063
[TBL] [Abstract][Full Text] [Related]
19. [Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice].
Naito T
Yakugaku Zasshi; 2010 Dec; 130(12):1695-700. PubMed ID: 21139397
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of mycophenolate mofetil.
Bullingham RE; Nicholls AJ; Kamm BR
Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
